Increasing Tysabri dosing interval may cut PML risk
Increasing Tysabri dosing interval may cut PML risk
Freedom from relapse was maintained in multiple sclerosis patients on Tysabri who received the infusion drug less frequently than the recommended 4-week interval, with lower risk of progressive multifocal leukoencephalopathy (PML), preliminary results from an ongoing analysis have indicated...... Read More - http://www.ms-uk.org/tysabri
MS-UK - http://www.ms-uk.org/
Re: Increasing Tysabri dosing interval may cut PML risk
Prior to any flag waving, please note that this is not a randomized double blind controlled trial...
Weinshenker commented that selection of patients for extended dosing, which was not random, might have involved "biases against committing more aggressive MS patients on the extended interval program, which might reduce the ability of the investigators to detect reduction in efficacy."
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2579 Views
-
Last post by NHE
-
- 0 Replies
- 552 Views
-
Last post by NHE
-
- 6 Replies
- 7810 Views
-
Last post by ElliotB
-
- 0 Replies
- 1424 Views
-
Last post by NHE
-
- 0 Replies
- 3811 Views
-
Last post by NHE
-
- 0 Replies
- 618 Views
-
Last post by NHE
-
- 0 Replies
- 3502 Views
-
Last post by NHE
-
- 1 Replies
- 1162 Views
-
Last post by NHE
-
- 11 Replies
- 3535 Views
-
Last post by NHE